A phase 2, adaptive randomized, double-blind, placebo-controlled, multicenter, 52-week study of HM15211 in patients with biopsy-confirmed non-alcoholic steatohepatitis – Study design and rationale of HM-TRIA-201 study
| Autor: | Abdelmalek, Manal F., Suzuki, Ayako, Sanchez, Willian, Lawitz, Eric, Filozof, Claudia, Cho, Hyungjin, Baek, Eunhye, Choi, JaeDuk, Baek, Seungjae |
|---|---|
| Zdroj: | In Contemporary Clinical Trials July 2023 130 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect